Related Experiment Video
Updated: Mar 6, 2026
09:44
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
10.0K
High-Throughput Dual Screening Method for Ras Activities and Inhibitors
Kari Kopra1, Arjan J van Adrichem2, Outi M H Salo-Ahen3
1Institute of Biomedicine, University of Turku , Kiinamyllynkatu 10 C, FI-20520 Turku, Finland.
Analytical Chemistry
|March 21, 2017
Summary
Researchers developed a new high-throughput screening method to find inhibitors for Ras-driven cancers. This novel assay monitors GTPase cycling, identifying potential drug compounds more effectively than traditional methods.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ras GTPases function as molecular switches, cycling between GDP-bound inactive and GTP-bound active states.
- Ras-oncogenes are implicated in numerous cancers, yet effective therapies remain elusive due to challenges in drug discovery, including inadequate screening methods and undefined binding pockets.
- Targeting Ras proteins is crucial for developing novel cancer treatments.
Purpose of the Study:
- To develop and validate a novel homogeneous quenching resonance energy transfer (QRET) technique-based screening strategy for Ras inhibitors.
- To establish an efficient high-throughput screening (HTS) method for identifying Ras interfacial and competitive inhibitors.
- To overcome limitations of existing screening methodologies for Ras-driven cancer therapies.
Main Methods:
- Development of a homogeneous quenching resonance energy transfer (QRET) assay for monitoring GTPase cycling.
- Utilized a unique GTP-specific antibody fragment to detect the active GTP-bound state of Ras proteins.
- Incorporated guanine nucleotide exchange factor (GEF) and GTPase activating protein (GAP) to simulate physiological GTPase regulation.
- Compared the novel assay with a conventional GEF-stimulated nucleotide exchange assay in a proof-of-concept screen.
Main Results:
- The QRET-based assay successfully monitored Ras GTPase cycling in real-time.
- The novel assay identified potential Ras inhibitor compounds, including those missed by conventional methods.
- A comparison revealed both overlapping and exclusive inhibitor candidates between the new and traditional assays, highlighting the new method's unique capabilities.
- Demonstrated the efficiency of using a GTP-specific antibody fragment for HTS of Ras inhibitors.
Conclusions:
- The developed QRET-based GTPase cycling assay is an efficient and effective method for high-throughput screening of Ras inhibitors.
- This novel screening strategy enhances the identification of potential therapeutic compounds for Ras-driven cancers.
- The approach addresses the need for improved methodologies in Ras-targeted drug discovery.
